Additionally, FGF1 has been utilized in another clinical trial (NCT06328166) to demonstrate the therapeutic efficacy and safety of ES135 (a recombinant human FGF1) for patients suffering from carpal tunnel syndrome. The gene discussed is FGF1; the disease is carpal tunnel syndrome.